Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
Sci Rep ; 10(1): 18262, 2020 10 26.
Artículo en Inglés | MEDLINE | ID: mdl-33106494

RESUMEN

The burden of antibiotic resistance is currently estimated by mathematical modeling, without real count of resistance to key antibiotics. Here we report the real rate of resistance to key antibiotics in bacteria isolated from humans during a 5 years period in a large area in southeast in France. We conducted a retrospective study on antibiotic susceptibility of 539,107 clinical strains isolated from hospital and private laboratories in south of France area from January 2014 to January 2019. The resistance rate to key antibiotics as well as the proportion of bacteria classified as Difficult-to-Treat (DTR) were determined and compared with the Mann-Whitney U test, the χ2 test or the Fisher's exact test. Among 539,037 isolates, we did not observe any significant increase or decrease in resistance to key antibiotics for 5 years, (oxacillin resistance in Staphylococcus aureus, carbapenem resistance in enterobacteria and Pseudomonas aeruginosa and 3rd generation cephalosporin resistance in Escherichia coli and Klebsiella pneumoniae). However, we observed a significant decrease in imipenem resistance for Acinetobacter baumannii from 2014 to 2018 (24.19-12.27%; p = 0.005) and a significant increase of ceftriaxone resistance in Klebsiella pneumoniae (9.9-24.03%; p = 0.001) and Enterobacter cloacae (24.05-42.05%; p = 0.004). Of these 539,037 isolates, 1604 (0.3%) had a DTR phenotype. Over a 5-year period, we did not observe a burden of AR in our region despite a high rate of antibiotic consumption in our country. These results highlight the need for implementation of real-time AR surveillance systems which use factual data.


Asunto(s)
Antibacterianos/uso terapéutico , Bacterias/efectos de los fármacos , Bases de Datos Factuales/estadística & datos numéricos , Farmacorresistencia Bacteriana , Pruebas de Sensibilidad Microbiana/métodos , Modelos Teóricos , Acinetobacter baumannii/efectos de los fármacos , Acinetobacter baumannii/aislamiento & purificación , Bacterias/clasificación , Bacterias/aislamiento & purificación , Escherichia coli/efectos de los fármacos , Escherichia coli/aislamiento & purificación , Francia , Humanos , Pseudomonas aeruginosa/efectos de los fármacos , Pseudomonas aeruginosa/aislamiento & purificación , Estudios Retrospectivos , Staphylococcus aureus/efectos de los fármacos , Staphylococcus aureus/aislamiento & purificación
2.
Med Mal Infect ; 49(2): 102-111, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-30765286

RESUMEN

Bacteria of the Borrelia burgdorferi sensu lato complex, responsible for Lyme disease, are members of the spirochetes phylum. Diagnostic difficulties of Lyme disease are partly due to the characteristics of spirochetes as their culture is tedious or even impossible for some of them. We performed a literature review to assess the value of the various diagnostic tests of spirochetes infections of medical interest such as Lyme borreliosis, relapsing fever borreliae, syphilis, and leptospirosis. We were able to draw similarities between these four infections. Real-time PCR now plays an important role in the direct diagnosis of these infections. However, direct diagnosis remains difficult because of a persistent lack of sensitivity. Serological testing is therefore crucial in the diagnostic process. All currently available diagnostic tools are imperfect, with a potential risk of false positive and false negative results depending on the clinical context. Physicians should always take into consideration the clinical and epidemiological context when Lyme disease, relapsing fever borreliae, syphilis, and leptospirosis are suspected.


Asunto(s)
Pruebas Diagnósticas de Rutina , Enfermedad de Lyme/diagnóstico , Spirochaetales/aislamiento & purificación , Antígenos Bacterianos/análisis , Antígenos Bacterianos/inmunología , Borrelia/inmunología , Borrelia/aislamiento & purificación , Grupo Borrelia Burgdorferi/inmunología , Humanos , Leptospira/inmunología , Leptospira/aislamiento & purificación , Reacción en Cadena de la Polimerasa , Pruebas Serológicas , Spirochaetales/inmunología , Treponema pallidum/inmunología , Treponema pallidum/aislamiento & purificación
3.
Intervirology ; 57(1): 43-8, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24157452

RESUMEN

In Europe, autochthonous hepatitis E is caused by genotype 3 hepatitis E virus (HEV) in almost all cases. A total of 15 infections with genotype 4 HEV were diagnosed in France from May 2009 to April 2012, and all but one of the HEV-4 strains implicated in these infections were genetically related and highly similar to HEV-4 sequences isolated from swine in Belgium. In addition, 5 autochthonous HEV-4 infections have been described in the region of Lazio, Italy, during March and April 2011, and these HEV sequences were 100% identical to one another but showed relatively low similarity (74-85%) to HEV-4 RNA samples collected in France. We report 6 additional HEV-4 infections that were diagnosed from May to July 2012 which represented 50% of the HEV infections diagnosed during this period in our clinical microbiology laboratory. Five of these HEV-4 strains were associated with autochthonous infections and were clustered together and with the majority of HEV-4 previously described in France, whereas the sixth strain was genetically divergent. Taken together with reports from other teams, these observations indicate that autochthonous infections with HEV-4 are emerging in Europe and have been transmitted by at least two distinct sources.


Asunto(s)
Enfermedades Transmisibles Emergentes/epidemiología , Enfermedades Transmisibles Emergentes/virología , Virus de la Hepatitis E/clasificación , Virus de la Hepatitis E/genética , Hepatitis E/epidemiología , Hepatitis E/virología , Análisis por Conglomerados , Francia/epidemiología , Genotipo , Virus de la Hepatitis E/aislamiento & purificación , Humanos , Italia/epidemiología , Filogenia , ARN Viral/genética
4.
Clin Infect Dis ; 51(2): 131-40, 2010 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-20540619

RESUMEN

BACKGROUND. Blood culture-negative endocarditis (BCNE) may account for up to 31% of all cases of endocarditis. METHODS. We used a prospective, multimodal strategy incorporating serological, molecular, and histopathological assays to investigate specimens from 819 patients suspected of having BCNE. RESULTS. Diagnosis of endocarditis was first ruled out for 60 patients. Among 759 patients with BCNE, a causative microorganism was identified in 62.7%, and a noninfective etiology in 2.5%. Blood was the most useful specimen, providing a diagnosis for 47.7% of patients by serological analysis (mainly Q fever and Bartonella infections). Broad-range polymerase chain reaction (PCR) of blood and Bartonella-specific Western blot methods diagnosed 7 additional cases. PCR of valvular biopsies identified 109 more etiologies, mostly streptococci, Tropheryma whipplei, Bartonella species, and fungi. Primer extension enrichment reaction and autoimmunohistochemistry identified a microorganism in 5 additional patients. No virus or Chlamydia species were detected. A noninfective cause of endocarditis, particularly neoplasic or autoimmune disease, was determined by histological analysis or by searching for antinuclear antibodies in 19 (2.5%) of the patients. Our diagnostic strategy proved useful and sensitive for BCNE workup. CONCLUSIONS. We highlight the major role of zoonotic agents and the underestimated role of noninfective diseases in BCNE. We propose serological analysis for Coxiella burnetii and Bartonella species, detection of antinuclear antibodies and rheumatoid factor as first-line tests, followed by specific PCR assays for T. whipplei, Bartonella species, and fungi in blood. Broad-spectrum 16S and 18S ribosomal RNA PCR may be performed on valvular biopsies, when available.


Asunto(s)
Endocarditis/diagnóstico , Endocarditis/etiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Enfermedades Autoinmunes/diagnóstico , Enfermedades Autoinmunes/patología , Infecciones Bacterianas/diagnóstico , Infecciones Bacterianas/microbiología , Niño , Endocarditis/patología , Femenino , Humanos , Inmunoensayo/métodos , Inmunohistoquímica/métodos , Masculino , Persona de Mediana Edad , Técnicas de Diagnóstico Molecular/métodos , Datos de Secuencia Molecular , Neoplasias/diagnóstico , Neoplasias/patología , Patología Molecular/métodos , Reacción en Cadena de la Polimerasa/métodos , Estudios Prospectivos , Adulto Joven
5.
Emerg Infect Dis ; 8(8): 865-8, 2002 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12141977

RESUMEN

We report a human case of leptospirosis in which the spirochete was detected by dark-field microscopy examination of cerebrospinal fluid (CSF) and isolated from both CSF and blood. Leptospira fainei was identified by sequencing the 16S rDNA gene, which had been amplified by polymerase chain reaction. This case confirms the role of L. fainei as a human pathogen and extends its distribution to southern Europe.


Asunto(s)
Leptospira/clasificación , Leptospira/aislamiento & purificación , Leptospirosis/microbiología , Adulto , Amoxicilina/uso terapéutico , Anticuerpos Antibacterianos/inmunología , Western Blotting , Electroforesis en Gel de Campo Pulsado , Humanos , Inmunoglobulina G/inmunología , Inmunoglobulina M/inmunología , Leptospira/genética , Leptospirosis/tratamiento farmacológico , Leptospirosis/inmunología , Masculino , Penicilinas/uso terapéutico , Filogenia , Reacción en Cadena de la Polimerasa , Especificidad de la Especie
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA